Report LibraryAll Reports
Datamonitor Healthcare Strategy: Orphan Drug Access and Pricing in Emerging Markets
Retail Price: $2,995.00*BioMedTracker Subscriber Price: $2,095.00 - click here to log in
January 12, 2018This analysis covers the four major emerging regions of the Middle East and Africa, Latin America, Eastern Europe, and Asia-Pacific. Within these regions, relatively wealthier markets with a proven marketplace for orphan medicines have been prioritized. The topic focus is on rare- disease policy, access, and pricing, as well as the stakeholder landscape for low-prevalence disorders and orphan drugs. For the purposes of this analysis, local definitions for rare disease were used where available, as well as conventional definitions of both “ultra-orphan” disorders and rare tumor types.
This Datamonitor Healthcare report contains a Strategy module.
|Disease Group Covered:||Not Specified|